NCT04787809

Brief Summary

Depression and anxiety are frequently comorbid and share mechanisms contributing to dysfunction. Transdiagnostic approaches, such as Acceptance and Commitment Therapy, streamline intervention and allow a broader population to benefit in a cost-effective fashion. Brief ACT interventions targeting at-risk individuals have the potential to prevent negative outcomes. Delivering these in a digital format overcomes attitudinal and structural barriers to accessing treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

February 19, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 19, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2021

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

9 months

First QC Date

February 3, 2021

Last Update Submit

April 14, 2025

Conditions

Keywords

Acceptance and Commitment Therapydigital mental healthdepressionanxietyemotional disorderspreventionexperiential avoidancevalues

Outcome Measures

Primary Outcomes (4)

  • Depression Anxiety Stress Scales-21 Depression Scale repeated measure of change

    Depression Anxiety Stress Scales-21 (DASS-21) is a 21 item self report questionnaire assessing symptoms of depression, anxiety, and stress. The DASS-21 seven item Depression Scale will be used to assess symptoms of depression and with higher scores indicating greater depressive symptoms. Scores on the DASS-21 Depression Scale range from 0 to 21.

    pre-intervention, two week post intervention, and four week post intervention

  • Depression Anxiety Stress Scales-21 Anxiety Scale repeated measure of change

    Depression Anxiety Stress Scales-21 (DASS-21) is a 21 item self report questionnaire assessing symptoms of depression, anxiety, and stress. The DASS-21 seven item Anxiety Scale will be used to assess symptoms of anxiety with higher scores indicating greater anxiety symptoms. Scores on the DASS-21 Anxiety Scale range from 0 to 21.

    pre-intervention, two week post intervention, and four week post intervention

  • Brief Experiential Avoidance Questionnaire repeated measure of change

    Brief Experiential Avoidance Questionnaire (BEAQ) is a 15 item self report measure assessing experiential avoidance. Higher scores on the BEAQ indicate greater experiential avoidance. Scores on the BEAQ can range from 15 to 90.

    pre-intervention, two week post intervention, and four week post intervention

  • Valuing Questionnaire-Progress Scale repeated measure of change

    Valuing Questionnaire-Progress Scale (VQ-P) is a five item scale assessing the extent to which one made progress towards one's values that is a part of the ten item Valuing Questionnaire. Higher scores on the VQ-P indicate greater progress towards one's values and VQ-P scores can range from 0 to 30.

    pre-intervention, two week post intervention, and four week post intervention

Other Outcomes (3)

  • COVID-19 Impact Indicators repeated measure of change

    Measured at baseline, 2 weeks post baseline, and 4 weeks post baseline

  • Cognitive Fusion Questionnaire

    Measured at baseline

  • Treatment Experience/Perceived Need Questions

    Measured at baseline

Study Arms (2)

Living Well Intervention Group

EXPERIMENTAL

Participants in the Living Well treatment group will receive a brief digital intervention informed by Acceptance and Commitment Therapy.

Behavioral: Living Well

Control Group

NO INTERVENTION

Participants in the control group will not receive any intervention. These individuals will have the option to access the intervention at the conclusion of their study participation.

Interventions

Living WellBEHAVIORAL

Living Well is a single session digital intervention that aims to decrease experiential avoidance and increase engagement in values-consistent behavior.

Living Well Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergraduate students aged 18 or older
  • Mildly to moderately elevated symptoms of depression or anxiety as reflected by DASS-21 Depression (5-10) or Anxiety scores (4-7).

You may not qualify if:

  • Participants under the age of 18
  • Severe or extremely severe scores on DASS-21 Depression (11 or greater) or Anxiety (8 or greater).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT Tyler

Tyler, Texas, 75701, United States

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Olga Berkout, PhD

    University of Texas at Tyler

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to a treatment (digital ACT-informed intervention) or control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychology

Study Record Dates

First Submitted

February 3, 2021

First Posted

March 9, 2021

Study Start

February 19, 2021

Primary Completion

November 19, 2021

Study Completion

November 19, 2021

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations